What is Phaarmasia share price return in the past 10 years?

Phaarmasia Ltd share price has appreciated 8.3% annually (CAGR) over the past ten years.

Phaarmasia Ltd - Stock Valuation and Financial Performance

Name: Phaarmasia
Brand: Phaarmasia

BSE: 523620 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Phaarmasia Share Price

₹46.43 -2.44 -4.99%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Phaarmasia

Based on:

Data

M-Cap below 100cr DeciZen not available

Phaarmasia stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

33.4 Cr.

52-wk low:

24.5

52-wk high:

64.8

Is Phaarmasia Ltd an attractive stock to invest in?

1. Is Phaarmasia Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Phaarmasia Ltd is a below average quality company.

2. Is Phaarmasia Ltd undervalued or overvalued?

The key valuation ratios of Phaarmasia Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Phaarmasia Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Phaarmasia Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Phaarmasia:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	5.3%	3.4%	3.6%	9.3%	10.4%	11.1%	5.2%	-18%	-19.2%	-8%	-
Value Creation Index ⓘ	-0.6	-0.8	-0.7	-0.3	-0.3	-0.2	-0.6	-2.3	-2.4	-1.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	18.7	21.6	14.4	20.2	24.2	24.5	19.9	17.2	27.5	30.6	29
Sales YoY Gr.	-	15.3%	-33.6%	40.5%	19.9%	1%	-18.6%	-13.5%	59.6%	11.3%	-
Adj EPS ⓘ	0	0.1	0.2	0.8	1.1	0.8	0.5	-2.3	-1.8	-0.8	-0.7
YoY Gr.	-	500%	300%	250%	26.2%	-25.5%	-41.8%	-593.5%	NA	NA	-
BVPS (₹) ⓘ	11.1	11.2	10.9	11.4	12.6	13.4	13.8	11.5	9.6	8.9	8.3
Adj Net Profit ⓘ	0	0	0.2	0.6	0.7	0.5	0.3	-1.6	-1.3	-0.5	0
Cash Flow from Ops. ⓘ	0.5	0.3	-0.1	0.9	0.1	0.1	0.3	-0.2	0.7	0.1	-
Debt/CF from Ops. ⓘ	0	0.1	-0.8	0.3	3.3	1.1	0.2	-0.2	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.6%	4.8%	15.4%	11.3%
Adj EPS ⓘ	-261.8%	-193.6%	-218.2%	NA
BVPSⓘ	-2.5%	-6.7%	-13.7%	-7.8%
Share Price	8.3%	22.9%	10%	72.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0.1	0.3	1.4	4.8	5.8	4.1	2.3	-12	-11	-4.9	-7.8
Op. Profit Mgn % ⓘ	5.1	1	0.9	2.4	3	3.4	-0.3	-10.1	-5.6	-2.7	-2.8
Net Profit Mgn % ⓘ	0	0.2	1.1	2.8	3	2.2	1.6	-9	-4.6	-1.7	-1.6
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	60	63	88	113	191	293	262	177	153	198	92
Cash Conv. Cycle ⓘ	-20	-44	-53	-39	-47	-14	2	6	-15	-34	-20

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 15.41%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -3.45%

Latest Financials - Phaarmasia Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.7	-
TTM Sales (₹ Cr.)	29.3	-
BVPS (₹.) ⓘ	8.3	-
Reserves (₹ Cr.) ⓘ	-1	-
P/BV ⓘ	5.86	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	24.50 / 64.75
All Time Low / High (₹)	0.05 / 420.00
Market Cap (₹ Cr.)	33.4
Equity (₹ Cr.)	6.8
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Phaarmasia:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Phaarmasia

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Phaarmasia

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	18.74	21.61	14.36	20.18	24.20	24.45	19.90	17.22	27.49	30.59
Operating Expenses ⓘ	17.78	21.39	14.23	19.69	23.47	23.63	19.96	18.95	29.03	31.41
Manufacturing Costs	5.03	5.58	6.27	8.93	8.10	8.36	5.28	5.84	11.08	10.03
Material Costs	4.07	4.11	4.27	7.25	11.16	12.42	12.21	10.55	14.88	18.23
Employee Cost	1.25	1.45	1.42	1.66	1.55	1.40	1.27	1.17	1.41	1.53
Other Costs ⓘ	7.43	10.26	2.27	1.84	2.65	1.46	1.20	1.40	1.66	1.63
Operating Profit ⓘ	0.96	0.22	0.13	0.49	0.73	0.82	-0.06	-1.74	-1.54	-0.82
Operating Profit Margin (%)	5.1%	1.0%	0.9%	2.4%	3.0%	3.3%	-0.3%	-10.1%	-5.6%	-2.7%
Other Income ⓘ	0.07	0.53	0.58	0.69	0.60	0.58	0.89	0.47	0.52	0.66
Interest ⓘ	0.03	0.01	0.01	0.04	0.04	0.04	0.01	0	0.04	0.04
Depreciation ⓘ	0.76	0.50	0.44	0.47	0.46	0.40	0.34	0.29	0.36	0.34
Exceptional Items ⓘ	0.13	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.36	0.24	0.27	0.68	0.83	0.96	0.48	-1.56	-1.43	-0.55
Tax ⓘ	0.22	0.20	0.10	0.11	0.05	0.42	0.17	-0.02	-0.17	-0.03
Profit After Tax	0.14	0.04	0.16	0.57	0.78	0.54	0.31	-1.55	-1.26	-0.52
PAT Margin (%)	0.7%	0.2%	1.1%	2.8%	3.2%	2.2%	1.6%	-9.0%	-4.6%	-1.7%
Adjusted EPS (₹)	0.2	0.1	0.2	0.8	1.1	0.8	0.5	-2.3	-1.8	-0.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	13.11	11.87	11.66	12.02	12.82	13.41	13.65	12.06	10.81	10.30
Share Capital ⓘ	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83	6.83
Reserves ⓘ	6.28	5.04	4.83	5.20	5.99	6.58	6.83	5.23	3.98	3.47
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0.05	0.12	0.16	0.08	0.05	0.03	0.01	0
Long Term Debt	0	0	0.05	0.12	0	0.03	0.02	0.01	0.01	0
Short Term Debt	0	0	0	0	0.16	0.05	0.03	0.02	0	0
Trade Payables	2.96	3.49	5.40	7.41	17.89	18.26	6.65	8.13	16.54	20.08
Others Liabilities ⓘ	3.25	3.28	2.44	2.37	2.38	1.85	1.56	0.98	1.01	0.99
Total Liabilities ⓘ	19.33	18.63	19.54	21.92	33.26	33.60	21.91	21.21	28.37	31.37
Fixed Assets
Gross Block	35.50	34.50	14.18	15.08	15.12	15.12	15.12	15.12	15.40	15.31
Accumulated Depreciation	19.89	20.38	0.44	0.91	1.33	1.72	2.07	2.36	2.61	2.84
Net Fixed Assetsⓘ	15.61	14.11	13.74	14.18	13.80	13.40	13.06	12.76	12.79	12.48
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	1.29	0.19	1.03	1.29	5.97	6.08	2.63	4.24	6.36	8.50
Trade Receivables	1.61	2.91	3.56	3.79	11.76	12.32	4.27	3.19	7.51	8.05
Cash Equivalents	0.28	0.44	0.15	0.19	0.19	0.15	0.38	0.22	0.69	0.63
Others Assetsⓘ	0.54	0.98	1.05	2.47	1.54	1.64	1.57	0.79	1.02	1.71
Total Assets ⓘ	19.33	18.63	19.54	21.92	33.26	33.60	21.91	21.21	28.37	31.37

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0.48	0.28	-0.08	0.88	0.06	0.08	0.25	-0.18	0.65	0.11
PBT ⓘ	0.36	0.24	0.27	0.68	0.83	0.96	0.48	-1.56	-1.43	-0.55
Adjustment ⓘ	0.79	0.51	0.43	0.26	0.48	0.47	0.25	0.24	0.38	0.35
Changes in Working Capital ⓘ	-0.59	-0.25	-0.68	0.07	-1.09	-1.09	-0.24	1.32	1.71	0.3
Tax Paid ⓘ	-0.08	-0.22	-0.11	-0.13	-0.17	-0.26	-0.24	-0.17	0	0
Cash Flow From Investing Activity ⓘ	-0.34	-0.28	-0.18	-0.92	-0.10	0	0	0.01	-0.01	0
Capex	-0.34	-0.28	-0.07	-0.90	-0.08	0	0	0	-0.03	-0.03
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	-0.11	-0.02	-0.02	0	0	0.01	0.01	0.03
Cash Flow From Financing Activityⓘ	0.12	0.16	-0.02	0.08	0.04	-0.11	-0.02	0	-0.16	-0.16
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.15	0.05	-0.02	0.08	0.04	-0.11	-0.02	0	-0.02	-0.01
Interest Paid ⓘ	-0.03	-0.01	0	0	0	0	0	0	-0.02	-0.04
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.13	0	0	0	0	0	0	-0.12	-0.11
Net Cash Flow ⓘ	0.26	0.17	-0.29	0.04	0	-0.03	0.23	-0.17	0.48	-0.06

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	1.86	0.55	2.16	7.54	9.51	6.08	3.36	-17.96	-17.5	-8.21
ROCE (%)	5.28	3.35	3.63	9.32	10.35	11.07	5.24	-18	-19.24	-7.95
Asset Turnover Ratio	1.15	1.14	1.05	1.03	0.93	0.73	0.72	0.8	1.11	1.02
PAT to CFO Conversion(x)	3.43	7	-0.5	1.54	0.08	0.15	0.81	N/A	N/A	N/A
Working Capital Days
Receivable Days	35	38	59	63	111	180	152	79	71	93
Inventory Days	16	13	11	20	52	90	80	73	70	89
Payable Days	198	287	379	322	414	531	372	256	303	367

Phaarmasia Ltd Stock News

Phaarmasia Ltd FAQs

What is the share price of Phaarmasia?

Company share prices are keep on changing according to the market conditions. The closing price of Phaarmasia on 21-Nov-2024 16:59 is ₹46.43.

What is the market cap of Phaarmasia?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Phaarmasia stood at ₹33.36.

What is the P/E ratio of Phaarmasia?

The latest P/E ratio of Phaarmasia as of 21-Nov-2024 16:59 is 0.00.

What is the P/B ratio of Phaarmasia?

The latest P/B ratio of Phaarmasia as of 21-Nov-2024 16:59 is 5.86.

What is the 52-week high and low of Phaarmasia?

The 52-week high of Phaarmasia is ₹64.75 and the 52-week low is ₹24.50.

What is the TTM revenue of Phaarmasia?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Phaarmasia is ₹29.29 ( Cr.) .

About Phaarmasia Ltd

The company was incorporated on February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

The company was established for carrying on the business as manufacturers, buyers, sellers, importers, exporters, distributors, agents and or otherwise deal as wholesalers, or retailers in drugs, medicines, pharmaceuticals, chemicals and other intermediates, dyes pigments, paints, rubber chemicals, phyto chemicals, hormones, agro-chemicals, veterinary and poultry products, food and nutritional products, house-hold remedies, biological and herbal products.

Phaarmasiaâ€™s registered office is located at 16,Phase III, I.D.A Jeedimetla, Hyderabad, Andhra Pradesh 500 055, India.

The company had restructured its Paid up Share Capital account of 91,34,800 Equity Shares of Rs 10 each fully paid up as on 31st, March,2005 by reducing / debiting the amount of Rs 730.78 lakhs for setting off the Accumulated Losses of the Company and has further allotted 50,00,000 Equity Shares of Rs 10each to promoters and Associates for Rs 250 lakhs and balance to Unsecured Creditors as approved in the above Scheme of Arrangement.

Product range of the company includes:

Phaarmasiaâ€™s product range includes amexine, angicare, flamfort, nasorel, flemkof, ginadox, medix and ziron. Its amexine is an antibiotic, which is used for upper respiratory tract infections, mucolytic and expectorant.

Company also provides nasorel PR, which is a therapeutic category that comes under antihistamine and sympathomimetic.